Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Apr 20;121(15):1746-55.
doi: 10.1161/CIRCULATIONAHA.109.924886. Epub 2010 Apr 5.

Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice

Affiliations

Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice

Emily Smith et al. Circulation. .

Abstract

Background: T cells play an important role during the immune response that accompanies atherosclerosis. To date, the role for interleukin (IL)-17A in atherogenesis is not well defined. Here, we tested the hypothesis that atherosclerosis-prone conditions induce the differentiation of IL-17A-producing T cells, which in turn promote atherosclerosis.

Methods and results: IL-17A was found to be elevated in the plasma and tissues of apolipoprotein E-deficient (Apoe(-/-)) mice. IL-17A-expressing T cells were significantly increased in the aortas, spleen, and lamina propria of aged Apoe(-/-) mice compared with age-matched C57BL/6 mice. IL-17A(+) T cells resided in both adventitia and aortas of aged Apoe(-/-) mice fed a chow diet. Elevated levels of IL-17A(+) T cells were also detected in the aortas of 21-week-old Apoe(-/-) mice fed a Western diet for 15 weeks. IL-17A(+) T cells were characterized as predominantly CD4(+) T helper 17 (Th17) cells and gammadelta(+) T cells. Blockade of IL-17A in Apoe(-/-) mice by use of adenovirus-produced IL-17 receptor A reduced plaque burden in Apoe(-/-) mice fed a Western diet for 15 weeks. In addition, the treatment diminished circulating IL-6 and granulocyte colony-stimulating factor levels and limited CXCL1 expression and macrophage content within the aortas. Conversely, IL-17A treatment of whole aorta isolated from Apoe(-/-) mice promoted aortic CXCL1 expression and monocyte adhesion in an ex vivo adhesion assay.

Conclusions: These results demonstrate that atherosclerosis-prone conditions induce the differentiation of IL-17A-producing T cells. IL-17A plays a proatherogenic inflammatory role during atherogenesis by promoting monocyte/macrophage recruitment into the aortic wall.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Basal levels of IL-17A are elevated in female and male Apoe−/− mice
(A) IL-17A mRNA was found elevated in the aorta, spleen, LP and PLN of Apoe−/− mice (white bars, n=6) compared to C57BL/6 mice (black bars, n=6). (B) mRNA expression of IL-17C, D, and IL-17F was normalized compared to IL-17A (set as 100%) in the aortas of Apoe−/− mice (n=8). (C) Serum IL-17A, TNF-α, IL-2 were analysed in the plasma of Apoe−/− (white bars, n=10–11) and C57BL/6 mice (black bars, n=10–11), (D) Neutrophil (PMN) counts are elevated in Apoe−/− mice (white bars, n=8) compared to C57BL/6 mice (black bars, n=5); white blood cells (WBC). *P<0.05, **P<0.01 by unpaired Students t test.
Figure 2
Figure 2. IL-17A+CD3+ and IL-17A+CD3int T cells are found elevated in female and male Apoe−/− mice
To examine leukocyte population within the analyzed tissues, a gate was set on CD45+ cells. (A) Representative FACS plot showing an elevation of IL-17A+CD45+CD3+ and IL-17A+CD45+ CD3int T cells in the aortas of aged Apoe−/− mice compared to C57BL/6 mice. (B) IL-17A+CD3+ T cells were found elevated in the aortas, spleen and LP of aged Apoe−/− (black bars, n=12) mice and 21 week old Apoe−/− mice fed WD (grey bars, n=4) compared to C57BL/6 mice (white bars, n=10). *p<0.05, **p<0.01 by unpaired Students t test with Bonferroni-Holm correction for multiple comparison (aorta and spleen). (C, D) Representative FACS plot of an aorta (C) and spleen (D) showing elevated IL-17A+ cells. The phenotype of (E) IL-17A-expressing cells in the aorta and spleen of C57BL/6 (grey bars) and Apoe−/− (black bars) mice. Results show mean ± SEM, n=6 mice from at least 3 independent experiments. (F) Representative image of isolated murine aortic adventitia and aorta. (G) Representative FACS plot showing the presence of IL-17A+ T cells in the adventitia and aortic wall of 45 week old Apoe−/− mice.
Figure 2
Figure 2. IL-17A+CD3+ and IL-17A+CD3int T cells are found elevated in female and male Apoe−/− mice
To examine leukocyte population within the analyzed tissues, a gate was set on CD45+ cells. (A) Representative FACS plot showing an elevation of IL-17A+CD45+CD3+ and IL-17A+CD45+ CD3int T cells in the aortas of aged Apoe−/− mice compared to C57BL/6 mice. (B) IL-17A+CD3+ T cells were found elevated in the aortas, spleen and LP of aged Apoe−/− (black bars, n=12) mice and 21 week old Apoe−/− mice fed WD (grey bars, n=4) compared to C57BL/6 mice (white bars, n=10). *p<0.05, **p<0.01 by unpaired Students t test with Bonferroni-Holm correction for multiple comparison (aorta and spleen). (C, D) Representative FACS plot of an aorta (C) and spleen (D) showing elevated IL-17A+ cells. The phenotype of (E) IL-17A-expressing cells in the aorta and spleen of C57BL/6 (grey bars) and Apoe−/− (black bars) mice. Results show mean ± SEM, n=6 mice from at least 3 independent experiments. (F) Representative image of isolated murine aortic adventitia and aorta. (G) Representative FACS plot showing the presence of IL-17A+ T cells in the adventitia and aortic wall of 45 week old Apoe−/− mice.
Figure 3
Figure 3. Apoe−/− mice treated with Ad-IL-17RA:Fc show a reduction in plaque burden over the whole aorta
(A) Lane 1–3, Detection of soluble IL-17RA in the plasma of an Apoe−/− mouse 7 days after Ad-IL-17RA:Fc treatment by immunoprecipitaion and western blot; lane-4, KO, (plasma from Il17ra−/− mice). (B) Western blot demonstrating the detection of sIL-17RA in the plasma of Apoe−/− mice injected with Ad-IL-17RA:Fc on the day of termination (21 week old Apoe−/− mice). Lane 1, KO-negative control (Il17ra−/− plasma), lane 2–6-experimental Apoe−/− mice. (C) Representative en face staining of aortas excised from 21 week-old (15 weeks on WD) Apoe−/− mice treated with Ad-IL-17RA:Fc (right) or Ad-Luc (left). (D) Lesion sizes for Apoe−/− mice treated with Ad-IL-17RA:Fc (n=7) or Ad-Luc (n=11), (% of whole aorta). Each symbol represents one animal, horizontal bars represent means. **P<0.01.
Figure 4
Figure 4. Decreased plasma levels of IL-6 and G-CSF in Apoe−/− mice treated with Ad-IL-17RA:Fc
Collected plasma supernatants from Apoe−/− mice treated with Ad-IL-17RA:Fc or with control Ad-Lu were analyzed for the presence of (A) IL-6, (B) IFN-γ, (C) G-CSF and (D) IL-17F. Results show mean±SE from 5 to 10 mice. *, P<0.05, **, P<0.01.
Figure 5
Figure 5. IL-17A increases monocyte adhesion to aortic wall via CXCL1
(A) Paraffin-embedded sections of aortic roots from 21 week old Apoe−/− mice that received either Ad-IL-17RA:Fc or Ad-Lu adenoviruses were stained with Abs against CXCL1 (A, brown) and Mac-2 (B, brown), and counterstained with hematoxylin (blue). Representative staining from one mouse is shown. Percentage of (C) CXCL1 and (D) Mac-2 positive staining relative to the total area of the aortic root. Values represent mean±SEM of 5 to 10 mice per group. (E) IL-17A-treated aortas show increased monocyte adhesion. Aortas were harvested from 25–30 week old Apoe−/− mice and treated with IL-17A as described in Materials and Methods. Fluorescently labeled monocytes (green) were added to aortas for an adhesion assay and adherent monocytes were counted by blinded observers using a fluorescent microscope. (F) Data represent the mean±SE of 3–4 counted aorta per group from 4 independent experiments. (G) Aortic mRNA expression. Total cellular RNA from vehicle-treated (white bars), IL-17A-treated (grey bars) and unwashed IL-17A-treated aortas (black bars) were examined for CXCL1 using quantitative real-time PCR. * P<0.05, ** P<0.01 by Student’s t test with Bonferroni-Holm correction for multiple comparison (for Fig. 5F and G). Data are from 3 independent experiments using 3–4 aortas per group.

Similar articles

Cited by

References

    1. Galkina E, Ley K. Immune and inflammatory mechanisms of atherosclerosis (*) Annu Rev Immunol. 2009;27:165–197. - PMC - PubMed
    1. Hansson GK, Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol. 2006;6:508–519. - PubMed
    1. Galkina E, Kadl A, Sanders J, Varughese D, Sarembock IJ, Ley K. Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent. J Exp Med. 2006;203:1273–1282. - PMC - PubMed
    1. Wick G, Romen M, Amberger A, Metzler B, Mayr M, Falkensammer G, Xu Q. Atherosclerosis, autoimmunity, and vascular-associated lymphoid tissue. FASEB J. 1997;11:1199–1207. - PubMed
    1. Zhou X, Paulsson G, Stemme S, Hansson GK. Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice. J Clin Invest. 1998;101:1717–1725. - PMC - PubMed

Publication types

MeSH terms

-